Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) EBITDA: 2013-2024

Historic EBITDA for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$42.4 million.

  • Armata Pharmaceuticals' EBITDA rose 53.45% to -$1.1 million in Q4 2018 from the same period last year, while for Dec 2018 it was -$15.9 million, marking a year-over-year increase of 1.58%. This contributed to the annual value of -$42.4 million for FY2024, which is 3.78% down from last year.
  • Latest data reveals that Armata Pharmaceuticals reported EBITDA of -$42.4 million as of FY2024, which was down 3.78% from -$40.9 million recorded in FY2023.
  • In the past 5 years, Armata Pharmaceuticals' EBITDA registered a high of -$21.6 million during FY2020, and its lowest value of -$42.4 million during FY2024.
  • Its 3-year average for EBITDA is -$40.1 million, with a median of -$40.9 million in 2023.
  • Data for Armata Pharmaceuticals' EBITDA shows a maximum YoY slumped of 55.09% (in 2022) over the last 5 years.
  • Over the past 5 years, Armata Pharmaceuticals' EBITDA (Yearly) stood at -$21.6 million in 2020, then declined by 10.35% to -$23.8 million in 2021, then tumbled by 55.09% to -$36.9 million in 2022, then declined by 10.68% to -$40.9 million in 2023, then fell by 3.78% to -$42.4 million in 2024.